Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia  

https://www.globenewswire.com/news-release/2018/05/28/1512592/0/en/Zealand-Pharma-reports-completion-of-the-second-and-pivotal-Phase-3-trial-with-dasiglucagon-for-the-treatment-of-severe-hypoglycemia.html

company announcement